Anticholinergic Drugs and Dementia
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Drug-Induced Angle-Closure Glaucoma
10.5005/jp-journals-10008-1100 ArujREVIEW K Khurana ARTICLE et al Drug-induced Angle-Closure Glaucoma Aruj K Khurana, Bhawna Khurana, Ashok K Khurana Regional Institute of Ophthalmology, Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India Correspondence: Ashok K Khurana, Senior Professor, Regional Institute of Ophthalmology, Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India ABSTRACT Drug-induced angle-closure glaucoma is an important entity for the ophthalmologist as well as the general physician as it represents a preventable cause of potential blindness. This brief review highlights the fact that a high index of suspicion, in a susceptible individual followed by confirmation on appropriate imaging modality (UBM, ultrasound or anterior segment OCT) can alleviate the threat to sight and also help to institute appropriate therapy. Keywords: Acute angle closure, Drug-induced glaucoma. INTRODUCTION factors exist for this syndrome.9 Other sulfa-based drugs known Drug-induced angle-closure glaucoma is an important entity to be associated with AACG: Acetazolamide, hydrochloro- 10 for the ophthalmologist as well as the general physician as it thiazide and cotrimoxazole. represents a preventable cause of potential blindness.1 Acute Anticholinergic drugs implicated in the causation of AACG angle-closure glaucoma can develop in a susceptible individual include atropine, homatropine, cyclopentolate and ipratropium by various classes of drugs.2 Practitioners using any of these bromide.10,11 Atropine is often used to treat bradycardia, drugs should be aware of their potential to cause acute angle especially related to general anesthesia. Postoperative AACG closure, such that a patient presenting with signs or symptoms has been reported in patients after general anesthesia for of acute angle closure should be immediately referred to an abdominal, orthopedic, facial and endoscopic surgery.12 3 ophthalmologist. -
Non-Steroidal Drug-Induced Glaucoma MR Razeghinejad Et Al 972
Eye (2011) 25, 971–980 & 2011 Macmillan Publishers Limited All rights reserved 0950-222X/11 www.nature.com/eye 1,2 1 1 Non-steroidal drug- MR Razeghinejad , MJ Pro and LJ Katz REVIEW induced glaucoma Abstract vision. The majority of drugs listed as contraindicated in glaucoma are concerned with Numerous systemically used drugs are CAG. These medications may incite an attack in involved in drug-induced glaucoma. Most those individuals with narrow iridocorneal reported cases of non-steroidal drug-induced angle.3 At least one-third of acute closed-angle glaucoma are closed-angle glaucoma (CAG). glaucoma (ACAG) cases are related to an Indeed, many routinely used drugs that have over-the-counter or prescription drug.1 Prevalence sympathomimetic or parasympatholytic of narrow angles in whites from the Framingham properties can cause pupillary block CAG in study was 3.8%. Narrow angles are more individuals with narrow iridocorneal angle. The resulting acute glaucoma occurs much common in the Asian population. A study of a more commonly unilaterally and only rarely Vietnamese population estimated a prevalence 4 bilaterally. CAG secondary to sulfa drugs is a of occludable angles at 8.5%. The reported bilateral non-pupillary block type and is due prevalence of elevated IOP months to years to forward movement of iris–lens diaphragm, after controlling ACAG with laser iridotomy 5,6 which occurs in individuals with narrow or ranges from 24 to 72%. Additionally, a open iridocorneal angle. A few agents, significant decrease in retinal nerve fiber layer including antineoplastics, may induce thickness and an increase in the cup/disc ratio open-angle glaucoma. -
Anticholinergic Drugs Improve Symptoms but Increase Dry Mouth in Adults with Overactive Bladder Syndrome
Source of funding: Evid Based Nurs: first published as 10.1136/ebn.6.2.49 on 1 April 2003. Downloaded from Review: anticholinergic drugs improve symptoms but Health Research Council of Aotearoa increase dry mouth in adults with overactive bladder New Zealand. syndrome For correspondence: Jean Hay-Smith, Hay-Smith J, Herbison P,Ellis G, et al. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Dunedin School of Cochrane Database Syst Rev 2002;(3):CD003781 (latest version May 29 2002). Medicine, University of Otago, Dunedin, New QUESTION: What are the effects of anticholinergic drugs in adults with overactive Zealand. jean.hay-smith@ bladder syndrome? otago.ac.nz Data sources Parallel arm studies of anticholinergic drugs v placebo for overactive bladder syndrome in Studies were identified by searching the Cochrane adults at 12 days to 12 weeks* Incontinence Group trials register (to January 2002) Weighted event rates and reference lists of relevant papers. Anticholinergic Study selection Outcomes drugs Placebo RBI (95% CI) NNT (CI) Randomised or quasi-randomised controlled trials in Self reported cure or adults with symptomatic diagnosis of overactive bladder improvement (8 studies) 63% 45% 41% (29 to 54) 6 (5 to 8) syndrome, urodynamic diagnosis of detrusor overactiv- RRI (CI) NNH (CI) ity, or both, that compared an anticholinergic drug Dry mouth (20 studies) 36% 15% 138 (70 to 232) 5 (4 to 7) (given to decrease symptoms of overactive bladder) with Outcomes Weighted mean difference (CI) placebo or no treatment. Studies of darifenacin, emepronium bromide or carrageenate, dicyclomine Number of leakage episodes in 24 hours (9 − chloride, oxybutynin chloride, propiverine, propanthe- studies) 0.56 (–0.73 to –0.39) Number of micturitions in 24 hours (8 studies) −0.59 (–0.83 to –0.36) line bromide, tolterodine, and trospium chloride were Maximum cystometric volume (ml) (12 studies) 54.3 (43.0 to 65.7) included. -
Solifenacin-Induced Delirium and Hallucinations☆
General Hospital Psychiatry 35 (2013) 682.e3–682.e4 Contents lists available at ScienceDirect General Hospital Psychiatry journal homepage: http://www.ghpjournal.com Case Report Solifenacin-induced delirium and hallucinations☆ Matej Štuhec, Pharm.D. ⁎ Ormoz Psychiatric Hospital, Department for Clinical Pharmacy, Slovenia, Ptujska Cesta 33, Ormoz, Slovenia article info abstract Article history: Solifenacin-induced cognitive adverse effects have not been reported frequently, but solifenacin-induced Received 11 April 2013 delirium and hallucinations with successful switching to darifenacin, without additional drug, have not been Revised 5 June 2013 reported in the literature. In this case report, we present an 80-year-old Caucasian male with insomnia and Accepted 5 June 2013 anxiety symptoms and overactive bladder who developed delirium and hallucinations when treated with Keywords: solifenacin and trazodone. After solifenacin discontinuation and switching to darifenacin, symptoms significantly improved immediately. Such a case has not yet been described in literature; however, an Solifenacin Delirium adverse effect associated with solifenacin can occur, as this report clearly demonstrates. Hallucinations © 2013 Elsevier Inc. All rights reserved. Darifenacin Antimuscarinic adverse effect Case report 1. Introduction tion of Diseases, 10th Revision (ICD-10)], and depression with psychotic features was ruled out with differential diagnosis. Patient reported Solifenacin is a competitive muscarinic receptor antagonist, which insomnia, fear, fatigue, nausea, chest pain, shortness of breath and is used for overactive bladder (OAB) treatment. It acts as an headache. Solifenacin (Vesicare) 5 mg daily in morning dose was antimuscarinic agent, showing the highest affinity for the muscarinic prescribed to him 1 week earlier by his physicians because of OAB. M(3) receptor, which mediates urinary bladder contraction. -
3 Drugs That May Cause Delirium Or Problem Behaviors CARD 03 19 12 JUSTIFIED.Pub
Drugs that May Cause Delirium or Problem Behaviors Drugs that May Cause Delirium or Problem Behaviors This reference card lists common and especially problemac drugs that may Ancholinergics—all drugs on this side of the card. May impair cognion cause delirium or contribute to problem behaviors in people with demena. and cause psychosis. Drugs available over‐the‐counter marked with * This does not always mean the drugs should not be used, and not all such drugs are listed. If a paent develops delirium or has new problem Tricyclic Andepressants Bladder Anspasmodics behaviors, a careful review of all medicaons is recommended. Amitriptyline – Elavil Darifenacin – Enablex Be especially mindful of new medicaons. Clomipramine – Anafranil Flavoxate – Urispas Desipramine – Norpramin Anconvulsants Psychiatric Oxybutynin – Ditropan Doxepin – Sinequan Solifenacin – VESIcare All can cause delirium, e.g. All psychiatric medicaons should be Imipramine – Tofranil Tolterodine – Detrol Carbamazepine – Tegretol reviewed as possible causes, as Nortriptyline – Aventyl, Pamelor Gabapenn – Neuronn effects are unpredictable. Trospium – Sanctura Anhistamines / Allergy / Leveracetam – Keppra Notable offenders include: Insomnia / Sleep Valproic acid – Depakote Benzodiazepines e.g. Cough & Cold Medicines *Diphenhydramine – Sominex, ‐Alprazolam – Xanax *Azelasne – Astepro Pain Tylenol‐PM, others ‐Clonazepam – Klonopin *Brompheniramine – Bromax, All opiates can cause delirium if dose *Doxylamine – Unisom, Medi‐Sleep ‐Lorazepam – Avan Bromfed, Lodrane is too high or -
Pharmacology of Ophthalmic Agents
Ophthalmic Pharmacology Richard Alan Lewis M.D., M.S., PHARMACOLOGY FOPS PHARMACOKINETICS OF Professor, Departments of Ophthalmology, • The study of the absorption, OPHTHALMIC Medicine, Pediatrics, and Molecular distribution, metabolism, AGENTS and Human Genetics and excretion of a drug or and the National School of Tropical agent Introduction and Review Medicine Houston, Texas PHARMACOKINETICS Factors Affecting Drug Penetration Factors Affecting Drug Penetration into Ocular Tissues • A drug can be delivered to ocular tissue: into Ocular Tissues – Locally: • Drug concentration and solubility: The higher the concentration the better the penetration, • Surfactants: The preservatives in ocular • Eye drop but limited by reflex tearing. preparations alter cell membrane in the cornea • Ointment and increase drug permeability, e.g., • Viscosity: Addition of methylcellulose and benzalkonium and thiomersal • Periocular injection polyvinyl alcohol increases drug penetration by • pH: The normal tear pH is 7.4; if the drug pH is • Intraocular injection increasing the contact time with the cornea and altering corneal epithelium. much different, it will cause reflex tearing. – Systemically: • Lipid solubility: Because of the lipid rich • Drug tonicity: When an alkaloid drug is put in • Orally environment of the epithelial cell membranes, relatively alkaloid medium, the proportion of the uncharged form will increase, thus more • IM the higher lipid solubility, the more the penetration. • IV penetration. FLUORESCEIN FLUORESCEIN Chemistry Dosage ● C20H1205, brown crystal ● Adults: 500-750 mg IV ● M.W. 322.3 e.g., 3 cc 25% solution ● Peak absorption 485-500 nm. 5 cc 10% solution ● Peak emission 520-530 nm. ● Children: 1.5-2.5 mg/kg IV Richard Alan Lewis, M.D., M.S. -
Anticholinergics for Overactive Bladder Evidence, Clinical Issues and Comparisons
Anticholinergics for Overactive Bladder Evidence, Clinical Issues and Comparisons RxFiles Academic Detailing Program March 2008 Saskatoon City Hospital 701 Queen Street, Saskatoon, SK S7K 0M7 www.RxFiles.ca Recent Guidelines: Overactive Bladder – Background • Special caution should be used for the elderly who Canadian Urological1: • Overactive bladder (OAB) is also known as urge are especially sensitive to side effects from ACs. Can J Urol. 2006;13(3):3127-38 incontinence and occurs when there is an inability Some with dementia or cognitive impairment may 2 not tolerate ACs at all. If using an AC in the NICE (UK) 2006 : to delay voiding when an urge is perceived. elderly, start at the lowest dose, titrate up and www.nice.org.uk/nicemedia/pdf/CG • OAB is differentiated from stress urinary 40fullguideline.pdf reassess for effectiveness and adverse effects. incontinence (SUI) which is associated with a loss of Remember that many drugs contribute to the total urine secondary to intra-abdominal pressure such as anticholinergic load (e.g. antidepressants, antipsychotics).14 Systematic Reviews: occurs with coughing, sneezing and exercise.9 Cochrane: Hay-Smith J et al. • ACs should not be used with acetylcholinesterase • Anticholinergics (ACs) are useful drugs for Which anticholinergics drug for inhibitors (e.g. ARICEPT, REMINYL, EXELON) given treating OAB, however their use is limited by the overactive bladder symptoms in their opposing mechanisms.23 adults. Cochrane Systematic side effects of dry mouth and constipation. 3 Reviews 2005, Issue 3. 4 Oregon 2005 : Are non-drug treatment options effective? Oxybutynin (Oxy) vs Tolterodine (Tol) • A Cochrane systematic review found 3: www.ohsu.edu/drugeffectiveness/rep • Bladder training (a gradual time lengthening orts/documents/OAB%20Final%20 no statistically significant differences for Report%20Update%203.pdf between voids) or urge suppression may be useful 10 patient perceived improvement, leakage Canada in OAB, especially in addition to ACs. -
Additional Drug Coverage
Additional Drug Coverage Additional prescription drug coverage Your plan includes extra coverage for certain drugs and supplies as shown below. This is not a complete list of prescription drugs and supplies covered by our plan. For a complete list, please call Customer Service toll-free at (866) 868-0609 (TTY: 711), 7 a.m. – 7 p.m. CT, Monday – Friday and 7 a.m. – 3 p.m. CT, Saturday. Lower-cost Medicare prescription drugs and supplies Your plan covers some of your Medicare prescription drugs and supplies at a $0 copay. If you have questions, call us toll-free at (866) 868-0609 (TTY: 711), 7 a.m. – 7 p.m. CT, Monday – Friday and 7 a.m. – 3 p.m. CT, Saturday. These drugs and supplies are part of your Medicare prescription drug coverage.1 Breast cancer preventive medications PEG-3350/NaCl/Na Bicarbonate/KCl TriLyte Anastrozole Exemestane Certain diabetic supplies for the Raloxifene administration of insulin Tamoxifen Insulin Syringes & Pen Needles Certain cholesterol-lowering medications Shingles vaccine Atorvastatin 10mg & 20mg Tablet Shingrix Lovastatin 10mg, 20mg & 40mg Tablet Zostavax Simvastatin 5mg, 10mg, 20mg & 40mg Tablet Tobacco cessation medications Certain colon prep products Buproban 150mg GaviLyte-C Chantix GaviLyte-G Nicotrol Inhaler PEG-3350/Electrolytes Nicotrol Nasal Spray Y0066_200527_081500_C Lower-cost non-Medicare over-the-counter drugs These drugs are covered in addition to the drugs in your plan’s drug list (formulary).2 Your plan covers these over-the-counter drugs at a $0 copay. Certain colon preparation products Tobacco cessation medications Bisacodyl Tablets Nicotine Gum Magnesium Citrate Solution Nicotine Lozenges Polyethylene Glycol Powder Nicotine Patches 1Information about the appeals and grievance process for these prescription drugs and supplies can be found in your Evidence of Coverage. -
Supplemental Table 1: Patient Characteristics, Interventions and Definitions/Variables of Persistence, Adherence and Discontinuation Reported in the Studies
Adherence and persistence to OAB medication Supplemental Table 1: Patient characteristics, interventions and definitions/variables of persistence, adherence and discontinuation reported in the studies. Author (year) and Definition of persistence/adherence/discontinuation and Length of country (database) Participants Drug/intervention* independent variables on persistence follow-up Brostrøm and Hallas n=2477 Any prescription of OAB Patients who continued taking a particular drug for up to 7 years with Up to 7 (2009)1 Male: n=836 (33.8%) medication: no more than 120-day gaps were regarded as experiencing single- years Odense University Female: n=1641 (66.2%) flavoxate (n=21) treatment episodes Pharmacoepidemio- Mean age: 68.3 yearsa oxybutynin TD (n=48) logical Database tolterodine (n=1478) Variables: age, gender, prior use of OAB agents and use of (OPED); Denmark) solifenacin (n=774) anti-diabetic drugs (1999–2006) trospium (n=271) darifenacin (n=52) Chancellor et al (2013)2 n=103 250 First (new) prescription of OAB To be considered a discontinuation, patients were required to have a 2 years IMS Lifelink Database, Male: n≈25 916a (25.1%) medication in adults ≥18 years: gap of at least 45 days in therapy based on fill dates and days’ Connecticut; USA Female: n≈77 334a (74.9%) tolterodine ER (n=43 881)a supply (2005–2008) Mean (SD) age: 58.7 (15.7) solifenacin (n=15 488)a years oxybutynin (n=15 075)a Adherence rate was defined as the proportion of patients filling more darifenacin (n=10 532)a than one prescription with an MPR of ≥80% oxybutynin -
Comparision Effects of Solifenacin, Darifenacin, Propiverine on Ocular Parameters in Eyes: a Prospective Study ______
ORIGINAL ARTICLE Vol. 46 (2): 185-193, March - April, 2020 doi: 10.1590/S1677-5538.IBJU.2019.0094 Comparision effects of solifenacin, darifenacin, propiverine on ocular parameters in eyes: A prospective study _______________________________________________ Mahmut Taha Ölçücü 1, Kerem Teke 1, Kadir Yildirim 2, Mesut Toğaç 3, Burcu Işık 3, Yusuf Cem Yilmaz 3 1 Department of Urology, Agri State Hospital, Agri, Turkey; 2 Department of Urology, Elaziğ Education and Research Hospital, Elazig, Turkey; 3 Department of Ophthalmology, Agri State Hospital, Agri, Turkey ABSTRACT ARTICLE INFO Objective: To evaluate the effects of solifenacin, darifenacin, and propiverine on Mahmut Taha Ölçücü nasal-, subfoveal-, temporal choroidal thicknesses (NCT, SFCT, TCT), intraocular http://orcid.org/0000-0002-4721-2807 pressure (IOP) and pupil diameter (PD). Materials and Methods: Patients with overactive bladder (OAB) diagnosed accord- Keywords: ing to The International Continence Society were administered with solifenacin, Pressure; Urinary Bladder; darifenacin or propiverine on a daily basis between November 2017 and May 2018. Overactive; Anisocoria NCT, SFCT, TCT, IOP, and PD of these patients were measured and compared as Int Braz J Urol. 2020; 46: 185-93 initial, fourth and twelfth weeks. Results: A total of 165 patients (330 eyes) with OAB were evaluated. Solifenacin (n=140) signifi cantly reduced IOP from 17.30±2.72 mmHg to 16.67±2.56 mmHg _____________________ (p=0.006) and 16.57±2.41 mmHg (p=0.002), at the fourth and twelfth weeks, re- Submitted for publication: spectively. Darifenacin (n=110) signifi cantly reduced NCT from 258.70±23.96 μm February 08, 2019 to 257.51±22.66 μm (p=0.002) and 255.36±19.69 μm (p=0.038), at the fourth and _____________________ twelfth weeks, respectively. -
World Health Organization Model List of Essential Medicines, 21St List, 2019
World Health Organizatio n Model List of Essential Medicines 21st List 2019 World Health Organizatio n Model List of Essential Medicines 21st List 2019 WHO/MVP/EMP/IAU/2019.06 © World Health Organization 2019 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. World Health Organization Model List of Essential Medicines, 21st List, 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. -
Anisocoria in a Patient with Acute Bronchiolitis Akut Bronşiyolitli Bir Hastada Anizokori
Case Report / Olgu Sunumu DOI: 10.5578/ced.201806 • J Pediatr Inf 2018; 12(1): e32-e34 Anisocoria in a Patient with Acute Bronchiolitis Akut Bronşiyolitli Bir Hastada Anizokori Neslihan Kara1, Seda Çelik1, Gözde Gürpınar1, Nazan Dalgıç2, İhsan Kafadar3 1 Department of Pediatrics, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey 2 Department of Pediatric Infectious Diseases, Sisli Etfal Hamidiye Training and Research Hospital, Istanbul, Turkey 3 Department of Pediatric Neurology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey Abstract Özet The term anisocoria refers to pupils that are of different sizes. The causes Anizokori, her iki pupillanın birbirinden farklı büyüklüklerde olması de- of anisocoria include physiological anisocoria, pharmacological anisoco- mektir. Anizokori nedenleri arasında fizyolojik anizokori, farmakolojik ria, cerebral neoplasms, and space occupying lesions such as aneurysms, anizokori, serebral neoplazi ve anevrizma gibi yer kaplayan oluşumlar and intracranial hemorrhage. The aim of the current manuscript is to ve intrakranial kanamalar bulunmaktadır. Burada akut bronşiyolit nede- present a 7-month old male case of sudden onset anisocoria who was niyle takip ettiğimiz, salbutamol ve ipratropium bromür tedavisi alan 7 on follow-up due to acute bronchiolitis and was receiving therapy with aylık erkek hastada ani gelişen anizokoriyi sunmayı amaçladık. salbutamol and ipratropium bromide. Anahtar Kelimeler: Anizokori, akut bronşiyolit, ipratropium bromür, Keywords: Anisocoria, acute bronchiolitis, ipratropium bromide, salbutamol salbutamol Introduction The causes of an abnormally small pupil include iridocy- clitis, previous eye surgery, pseudoexfoliation syndrome or Anisocoria can be the result of physiological factors but may pharmacological constriction caused by topical agents such as also occur in life-threatening conditions.